These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 12025249

  • 1. [Erroneous attitudes in the use of neuromuscular blocking agents].
    Ortiz-Gómez JR.
    Rev Esp Anestesiol Reanim; 2002 Feb; 49(2):65-8. PubMed ID: 12025249
    [No Abstract] [Full Text] [Related]

  • 2. A survey of current management of neuromuscular block in the United States and Europe.
    Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ.
    Anesth Analg; 2010 Jul; 111(1):110-9. PubMed ID: 19910616
    [Abstract] [Full Text] [Related]

  • 3. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G, Pompei L.
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
    Lee C, Katz RL.
    J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical limitations of acetylcholinesterase antagonists.
    Caldwell JE.
    J Crit Care; 2009 Mar; 24(1):21-8. PubMed ID: 19272535
    [Abstract] [Full Text] [Related]

  • 14. Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival.
    Bronsert MR, Henderson WG, Monk TG, Richman JS, Nguyen JD, Sum-Ping JT, Mangione MP, Higley B, Hammermeister KE.
    Anesth Analg; 2017 May; 124(5):1476-1483. PubMed ID: 28244947
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Case-Based Management of Neuromuscular Block, Reversal, and Recovery: Ensuring Optimal Outcomes.
    AANA J; 2015 Dec; Suppl():4-15. PubMed ID: 26749974
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine.
    Miller RD, Ward TA.
    Anesth Analg; 2010 Jul; 111(1):3-5. PubMed ID: 20576958
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.